Literature DB >> 6325346

Granulocyte response to oxidized FMLP. Evidence for partial inactivation of FMLP.

K Van Dyke, V Castranova, C J Van Dyke, J Ma, K Michaux, K W Mollison, G W Carter.   

Abstract

We prepared FMoxLP by oxidation of FMLP and evaluated its ability to trigger a variety of granulocyte responses. FMoxLP was found to depolarize granulocyte membranes; increase granulocyte oxygen consumption, superoxide production, and hydrogen peroxide production; compete with FMLP for binding to granulocytes; and stimulate granulocyte chemotaxis. Against all of these granulocyte functions, FMoxLP was considerably less potent than the parent FMLP. When luminol-dependent-granulocyte chemiluminescence (CL) was studied, FMoxLP was observed to be a more potent stimulus of this response than FMLP. This increased CL activity of FMoxLP may be related to nonoxidative burst mechanisms. Our results indicate that FMoxLP retains a significant amount of the biological activity of FMLP (albeit in general less potent). The biological importance of the observed activities of FMoxLP must await further investigation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325346     DOI: 10.1007/bf00918356

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  14 in total

Review 1.  Molecular and cellular mechanisms of leukocyte chemotaxis.

Authors:  R Snyderman; E J Goetzl
Journal:  Science       Date:  1981-08-21       Impact factor: 47.728

2.  Chemotactic factor inactivation by myeloperoxidase-mediated oxidation of methionine.

Authors:  R A Clark; S Szot; K Venkatasubramanian; E Schiffmann
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

3.  Effects of F-met-leu-phe and zymosan-activated serum on rat neutrophils in vivo.

Authors:  R B Gilbertsen; G W Carter; D J Quinn
Journal:  J Reticuloendothel Soc       Date:  1980-05

4.  Further studies on the structural requirements for synthetic peptide chemoattractants.

Authors:  R J Freer; A R Day; J A Radding; E Schiffmann; S Aswanikumar; H J Showell; E L Becker
Journal:  Biochemistry       Date:  1980-05-27       Impact factor: 3.162

5.  H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors.

Authors:  R K Root; J Metcalf; N Oshino; B Chance
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

6.  Oxidation of n-formyl methionyl chemotactic peptide by human neutrophils.

Authors:  M F Tsan; R C Denison
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

7.  Inhibition by nonsteroidal antiinflammatory drugs of luminol-dependent human-granulocyte chemiluminescence and [3H]FMLP binding. Effect of sulindac sulfide, indomethacin metabolite, and optical enantiomers (+) and (-) MK830.

Authors:  K Van Dyke; D Peden; C Van Dyke; G Jones; V Castranova; J Ma
Journal:  Inflammation       Date:  1982-03       Impact factor: 4.092

8.  Chemotactic factor inactivation by stimulated human neutrophils mediated by myeloperoxidase-catalyzed methionine oxidation.

Authors:  R A Clark; S Szot
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

9.  A new screening system for nonsteroidal anti-inflammatory drugs based upon inhibition of chemiluminescence produced from human cells (granulocytes).

Authors:  K Van Dyke; C Van Dyke; J Udeinya; C Brister; M Wilson
Journal:  Clin Chem       Date:  1979-09       Impact factor: 8.327

10.  Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.

Authors:  L T Williams; R Snyderman; M C Pike; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

View more
  3 in total

1.  Chemiluminescence and chemotaxis assay of canine granulocytes: a methodological study.

Authors:  G Trowald-Wigh; K Thorén-Tolling
Journal:  Acta Vet Scand       Date:  1990       Impact factor: 1.695

Review 2.  Pulmonary reactions to organic dust exposures: development of an animal model.

Authors:  V Castranova; V A Robinson; D G Frazer
Journal:  Environ Health Perspect       Date:  1996-03       Impact factor: 9.031

3.  Extracts of feverfew inhibit mitogen-induced human peripheral blood mononuclear cell proliferation and cytokine mediated responses: a cytotoxic effect.

Authors:  L A O'Neill; M L Barrett; G P Lewis
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.